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TERRAs are long non-coding RNAs generated from the telomeres. Lack of TERRA knockout
models has hampered understanding TERRAs’ functions. We recently identiﬁed chromosome
20q as one of the main origins of human TERRAs, allowing us to generate the ﬁrst 20q-
TERRA knockout models and to demonstrate that TERRAs are essential for telomere length
maintenance and protection. Here, we use ALT 20q-TERRA knockout cells to address a direct
role of TERRAs in telomeric heterochromatin formation. We ﬁnd that 20q-TERRAs are
essential for the establishment of H3K9me3, H4K20me3, and H3K27me3 heterochromatin
marks at telomeres. At the mechanistic level, we ﬁnd that TERRAs bind to PRC2, responsible
for catalyzing H3K27 tri-methylation, and that its localization to telomeres is TERRA-
dependent. We further demonstrate that PRC2-dependent H3K27me3 at telomeres is
required for the establishment of H3K9me3, H4K20me3, and HP1 binding at telomeres.
Together, these ﬁndings demonstrate an important role for TERRAs in telomeric hetero-
chromatin assembly.
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Telomeres are nucleoprotein structures at the ends ofchromosomes that protect them from being recognized asDNA double-strand breaks, thus preventing chromosomal
end-to-end fusions1. In vertebrates, telomeres consist of tandem
repeats of the TTAGGG sequence bound by the so-called telo-
mere-binding proteins or shelterin, which are essential for the
formation of a functional telomere cap2. Telomere repeats can be
generated de novo by telomerase, a reverse transcriptase (TERT)
that elongates chromosome ends by using an RNA component
(TERC) as template1. In mice and humans, telomerase is highly
expressed in embryonic pluripotent stem cells, and this expres-
sion is downregulated after birth leading to progressive telomere
erosion with aging owing to the incomplete replication of linear
chromosomes3,4. In contrast, cancer cells aberrantly overexpress
telomerase allowing for the ability of cancer cells to proliferate
indeﬁnitely5. Cancer cells can also use an independent mechan-
ism to elongate telomeres known as alternative lengthening of
telomeres (ALT), that is based on homologous recombination
between telomeric sequences6.
Interestingly, both telomere length and telomere recombina-
tion are subjected to a higher-order regulation involving epige-
netic modiﬁcations of the telomeric chromatin7. In particular,
mammalian telomeres are enriched in heterochromatic marks,
including HP1 binding, H3K9 and H4K20 tri-methylation
histone marks, as well as hypermethylation of subtelomeric
DNA7–13. These marks have been proposed to negatively regulate
telomere length and telomere recombination7. In particular, cells
lacking the histone methyltransferases Suv39 or Suv420, as well as
cells lacking the DNA methyltransferases DNMT1 and 3 have
markedly elongated telomeres9,11,12. Thus, disruption of this
silent chromatin environment results in loss of telomere-length
control and in increased telomere recombination. In turn, our
group also showed that progressive telomere loss associated to cell
division reduces chromatin compactation at telomeric and sub-
telomeric domains, which may favor telomere-elongation
mechanisms7,8,13. Telomere chromatin also shows a decrease of
heterochromatic histone marks during nuclear reprogramming14,
coinciding with net telomere elongation by telomerase14.
Despite the heterochromatic environment of the telomere,
telomeres are transcribed giving rise to long non-coding
UUAGGG-repeat transcripts known as Telomeric repeat-
containing RNAs (TERRAs) or TelRNAs15,16. TERRAs are
transcribed from the subtelomere toward the telomere and show a
spotted nuclear pattern as detected by RNA-FISH15,16. A pro-
portion of TERRAs spots colocalizes with telomeres, suggesting
that TERRAs are part of the telomeric chromatin15,16. At telo-
meres, TERRAs are essential to maintain telomere length and
telomere protection17–20, and therefore can be considered as bone
ﬁde telomere components. TERRAs have been also recently found
to bind to extratelomeric regions, explaining the non-telomeric
TERRA spots17.
TERRAs have been implicated in telomere protection17–21,
heterochromatin formation21, telomere replication22,23, and in
telomere elongation by homologous recombination through the
formation of DNA-TERRA hybrids24–26. However, under-
standing of TERRA in vivo function and the direct involvement
of TERRA in all the above-mentioned processes is largely pending
owing to lack of loss-of-function TERRA models. In this regard,
we recently identiﬁed the mouse and the human TERRA
locus18,20. We found that in both human and mouse, TERRAs do
not arise from all chromosomes but from a few of them18,20. In
human cells, the majority of TERRAs arise from a single locus in
chromosome 20q20. This allowed us to ﬁrst generate knockout
cells for this locus, which showed markedly reduced TERRA
levels, thus demonstrating that 20q is the main origin of human
TERRAs. 20q-TERRA knockout cells also demonstrated that
TERRAs are essential for telomere maintenance and telomere
protection20. Here, we use this human TERRA loss of function
model to assess a direct role of TERRA long non-coding RNAs in
telomeric heterochromatin formation, as well as unveil the
underlying molecular mechanisms.
In particular, there is mounting evidence that non-coding
RNAs are involved in heterochromatin formation across species
both through cis and trans mechanisms. This includes dosage
compensation in mammals, imprinting, and demarcation of
gene-silencing chromosomal domains27,28. In addition, non-
coding RNAs transcribed at centromeres are also proposed to be
involved in higher-order chromatin structures, and their tran-
scription to be important for the deposition of CenH3 (homo-
logous centromere-speciﬁc histone H3 variants; ref. 29).
In the case of TERRAs, not only do they colocalize with telo-
meric chromatin in cis and trans15,16,18, but they can also form
DNA–RNA hybrids or R-loops at the telomere24–26, a type of
structure shown to epigenetically modify the genome30,31. TER-
RAs have also been shown to interact with HP1 and H3K9me321.
Intriguingly, TERRAs have been proposed to correlate with
H3K27 deposition at extratelomeric sites, a histone mark placed
by EZH2, the catalytic subunit of the Polycomb repressive com-
plex 2 (PRC2). However, whether TERRAs regulate H3K27
deposition at telomeres or, more generally, whether TERRAs have
a direct role in the establishment of telomeric chromatin status is
largely unknown owing to the lack of KO models for TERRAs.
Here, we set to address a direct involvement of TERRAs in the
regulation of a higher-order regulation of chromatin at telomeres
by using a panel of human 20q-TERRA KO cells with markedly
reduced TERRA levels. We ﬁnd that depletion of TERRAs in
human U2OS cells cause a strong loss of H3K9me3 and
H4K20me3 tri-methylation histone marks at telomeric chroma-
tin, demonstrating direct involvement of TERRAs in the estab-
lishment of telomeric heterochromatin. In addition, we make the
ﬁnding that human telomeres are enriched for the H3K27m3 tri-
methylation facultative heterochromatin mark, which is catalyzed
by the PRC2 complex, and that this mark is also decreased in
20q-TERRA KO cells. Indeed, we describe here that TERRAs
directly bind the PRC2 complex components EZH2 and SUZ12
and that this binding is critical for PRC2 recruitment to telo-
meres. We further demonstrate that PRC2 at telomeres is
required for the establishment of H3K27me3, H3K9me3,
H4K20me3, and HP1 binding at telomeres. In summary, we
describe for the ﬁrst time a role for PRC2 in the establishment of
telomeric chromatin, which is regulated by TERRAs, thus
demonstrating an important role for TERRAs in telomeric het-
erochromatin assembly.
Results
Generation of a panel of 20q-TERRA KO cells. We ﬁrst gen-
erated a large panel of human U2OS cells KO for the 20q-TERRA
locus with the CRISPR-Cas9 system using the same strategy
described by us20. To increase the efﬁcacy of deletion we used an
all-in-one plasmid system32, which contains the two gRNAs (E1
and S2) under the U6 promoter, the Cas9 protein, and a GFP
cassette (see Materials and Methods; Fig.1a). EGFP-positive cells
were sorted by ﬂow cytometry and after PCR screening, we
obtained eight clones that carried the deletion in homozygosis
(clones #A7, E1, E6, E8, and H8; Fig. 1b). As controls, U2OS cells
were electroporated with the same plasmid but without gRNAs
(control clones #1 and #2). As expected, deletion of the 20q-
TERRA locus resulted in a signiﬁcant reduction in total TERRA
levels in the deleted clones (A7, E1, E6, E8, and H8) compared
with the original U2OS cellular pool and with the WT clones (#1
and 2; Fig. 1c), as determined by dot-blot analysis. Note that,
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Fig. 1 Deletion of the TERRA-20q locus markedly affects TERRA expression. a Scheme depicting the WT and the CRISPR-deleted allele for the 20q-TERRA
locus located in the subtelomere of the chromosome 20, q-arm. The position of the gRNAs (E1 and S2) and the primers used to genotype the deletions are
also shown. The black arrows represent the primers to amplify the CRISPR-deleted allele and the white arrows the ones to amplify the WT allele located
inside the 20q-TERRA locus. b Ethidium bromide gels showing the WT and the CRISPR-deleted allele for the 20q-TERRA locus detected by PCR in a WT
cellular pool and in different clones of the U2OS cells. c RNA from the a WT cellular pool, WT expanded clones (#1 and 2), or 20q-TERRA KO clones (#A7,
E1, E6, E8, and H8) from the USOS cell line was isolated and used for TERRA detection by RNA dot-blot with a probe against the TERRA-UUAGGG-tract;
18S serves as loading control. (Graph) TERRA quantiﬁcation normalized by 18S (mean values ± s.e.m., n= 3 biological replicates). d Representative
confocal microscopy images of RNA-FISH against TERRA-UUAGGG-tract (green) in the U2OS WT clones (#1 and 2) and in the 20q-TERRA KO clones
(#A7, E1, E6, E8, H8, and C4). Scale bar, 10 μm. (Graph) Quantiﬁcation of the total spot intensity per nucleus normalized by nucleus area (mean values ± s.
e.m., n= cells analyzed). One-way ANOVA with Dunnett’s post test was used for the statistical analysis (*p < 0.05, **p < 0.01, and ***p < 0.001)
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Fig. 2 Deletion of the 20q-TERRA locus decreases telomere length. a Representative frequency graphs of telomere length distribution (a.u.) measured in the
U2OS WT pool (black), in the WT clones (#1 and 2; dark gray), and in the 20q-TERRA KO clones (#A7, E1, E6, and C4; light gray). The mean telomere length
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and in the 20q-TERRA KO clones (#A7, E1, E6, and C4) by HT-Q-FISH (mean values ± s.e.m., n= technical replicates). c Graph showing the percentage of short
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technical replicates). One-way ANOVA with Dunnett’s post test was used for the statistical analysis (*p < 0.05, **p < 0.01, and ***p < 0.001)
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since the 20q-TERRA locus is an important TERRA locus but not
the only one20, we do not expect the complete abolition of
TERRA expression in the 20q-TERRA KO clones. Moreover, the
fact that in some of the 20q-TERRA KO clones the TERRA
downregulation is only 20–50% might be related to (1) the
adaptation to the cell culture conditions during clonal cell
expansion and (2) the compensation of other loci, for example,
the Xp20 locus or others. Nevertheless, 20q-TERRA is the only
locus in which a formal demonstration of its TERRA genuineness
has been carried out by genetic means so far20. We conﬁrmed
TERRA's downregulation by RNA-FISH using probes to detect
the TERRA’s -UUAGGG-repeat. In particular, we found a sig-
niﬁcant 20–50% reduction in total TERRA levels in the 20q-
TERRA KO clones compared to the controls (Fig. 1d). The 20q-
TERRA KO C4 clone from our previous work20 was included in
this analysis in parallel with the newly generated clones (Fig. 1d).
Next, we set to conﬁrm whether the newly generated 20q-
TERRA KO clones also showed a telomere-shortening phenotype
as previously described20. To this end, we performed telomeric
quantitative FISH (Q-FISH) to quantify telomere ﬂuorescence
and also included formerly generated 20q-TERRA KO clone C4
as control20. As shown in Fig. 2, deletion of the 20q-TERRA locus
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in the new clones and in the C4 clone resulted in a marked loss of
telomeric sequences as seen in the switch of the distribution of
telomere length frequencies toward lower values (Fig. 2a) and in
the signiﬁcant decrease in telomere ﬂuorescence intensity
(Fig. 2b). This was concomitant with a signiﬁcant increase in
the percentage of very short telomeres as determined by low
telomere ﬂuorescence (short telomeres considered those in the
10th percentile of the total telomere length distribution; Fig. 2c).
We observed no differences between the pool and the WT clone
#1 and an increase in telomeric length between the pool and the
WT clone #2 (Fig. 2b) that could be explained as a phenomenon
related to cell expansion.
In summary, the new 20q-TERRA KO clones generated here
reproducibly show marked TERRA downregulation and
decreased telomere length, thus supporting that the 20q locus is
a bona ﬁde TERRA origin in human U2OS cells.
TERRAs' assembly heterochromatic histone marks at telo-
meres. To address the role of TERRAs in telomeric chromatin
formation, we evaluated the impact of 20q-TERRA deletion on
the abundance of different histone marks at telomeres. To this
end, we used chromatin immunoprecipitation (ChIP), followed
by dot-blot (Methods). We ﬁrst conﬁrmed the presence of het-
erochromatic histone marks previously shown by us to be enri-
ched at telomeres, namely tri-methylated H3K9me3 and
H4K20me311,12 (Fig. 3a,b). Interestingly, we found that TERRA
downregulation in the different 20q-TERRA KO clones resulted
in a signiﬁcant decrease in abundance of H3K9m3 and
H4K20me3 heterochromatic marks at telomeres compared to the
WT pool and WT clones (Fig. 3a,b). These ﬁndings indicate a role
for TERRAs in the establishment of these telomeric hetero-
chromatin marks. Note that the apparent lack of “dose–response”
between TERRA levels and heterochromatic marks at telomeres
might be related to the clonal expansion and growth adaptation of
the U2OS tumoral cell line.
Next, we studied the abundance of active chromatin histone
marks at telomeric chromatin, such as H3K4m3, as well as
histone acetylation H3K9ac and H4K16ac marks. However, we
did not ﬁnd that TERRA levels signiﬁcantly affected any of these
active chromatin marks (Fig. 3c–e), indicating that TERRAs do
not regulate active transcription histone marks at telomeres.
TERRAs are essential for deposition of H3K27me3 at telo-
meres. The facultative heterochromatin mark, H3K27me3, is
established by the polycomb complex 2 and has been recently
shown to cooperate with the heterochromatic histone mark
H3K9me3 to recruit HP1 to heterochromatin33. In spite of the
fact that telomeres are enriched in both HP1 and H3K9me3, a
role for H3K27me3 at telomeres has not been explored before.
Here, we set to address whether H3K27me3 is present at human
telomeres and whether the abundance of this mark is inﬂuenced
by TERRA levels. Interestingly, we found that TERRA down-
regulation in the different 20q-TERRA KO clones resulted in a
signiﬁcant decrease in abundance of H3K27me3 marks at telo-
meres compared to the WT pool and WT clones (Fig. 3f),
demonstrating that TERRAs regulate the assembly of H3K27me3
at telomeres. The fact that all 20q-KO clones undergo similar
changes at these heterochromatic marks, similar changes in
TERRA levels, and have the same telomeric phenotype (see
above) supports that the changes observed are not due to the
accumulation of mutations during cell culture, to the monoclonal
expansion, or to the presence of CRISPR off-targets. Together,
these ﬁndings show that TERRAs are needed for the assembly of
H3K9me3, H4K20me3, and H3K27me3 histone chromatin marks
at telomeres, thus demonstrating a role for TERRAs in the
establishment of telomeric heterochromatin.
TERRAs bind PRC2 and regulates its recruitment to telomeres.
The ﬁnding of TERRA-dependent assembly of H3K27m3 at tel-
omeres prompted us to investigate whether TERRAs directly
regulate the presence at telomeric chromatin of the polycomb
PRC2 complex responsible for catalyzing the methylation of
H3K2734. First, we set to address a direct interaction between
TERRAs and PRC2 components. To this end, we performed a
TERRA biotin pull-down assay followed by western blot to detect
PRC2 components. For speciﬁc TERRA binding, we incubated
U2OS cells' nuclear extracts with a biotinylated oligo consisting of
eight TERRA-UUAGGG repeats (8 × UUAGGG; Methods). As a
negative control, we used a biotinylated oligo consisting of eight
CCCUAA repeats (8 × CCUAA; the TERRA antisense sequence),
as well as beads alone. To detect presence of the PRC2 complex in
the pull-down we used antibodies against two of core proteins of
the PRC2 complex, EZH2 and SUZ12. Importantly, we found that
both EZH2 and SUZ12 were able to speciﬁcally bind to the sense
TERRA oligo (“S” in Fig. 4a) but not to the control antisense oligo
(“AS” in Fig. 4a). Similarly, we could not detect EZH2 and SUZ12
when only the beads were incubated with the cell extracts (“no
oligo“ in Fig. 4a). These ﬁndings demonstrate that the PRC2
complex speciﬁcally interacts with TERRA RNAs. During the
preparation of this manuscript, the TERRA–PRC2 interaction
was also proven by electrophoretic mobility shift assay using a
recombinant holo-PRC2 5-mer complex (EZH2, EED, SUZ12,
RBBP4, and AEBP2) and a TERRA oligo35. The authors also
found that PRC2 has a general afﬁnity for G-rich RNA especially
those capable of folding into G-quadruplexes35. Later on, Chu
and co-workers demonstrated the direct interaction between
TERRAs and EZH2 by iDRIP (identiﬁcation of direct RNA-
interacting proteins)17, which reinforces our ﬁndings.
We next set to address whether PRC2 is speciﬁcally located at
telomeres and whether TERRAs are necessary for its telomeric
location. To this end, we used immunoﬂuorescence to evaluate
the presence of the SUZ12 PRC2 component at telomeres. As
Fig. 4 TERRAs bind PRC2 and modulates its own and HP1 recruitment to telomeres. a A TERRA biotinylated RNA oligo (S) was incubated with nuclear
extracts from U2OS cells and their association with Ezh2 and SUZ12 was detected by western blotting. A biotinylated control RNA oligo corresponding to
the complementary sequence (AS) of the same length as the biotinylated TERRA (N48) was used as control. Biotin pull-down in the absence of RNA oligo
(no oligo) was included to monitor inespeciﬁc binding to the beads. b Representative images of the average number of colocalizations found on double
immunostaining to TRF2 (green) and SUZ12 (red) in the U2OS WT and 20q-KO clones. Arrowheads indicate colocalization events. Scale bar, 10 μm. (Left
graph) Quantiﬁcation of the colocalization in each of the WT and 20q-TERRA KO clones (mean values ± s.e.m., n= number of cells) and (right graph) in all
WT vs. the 20q-TERRA KO clones (mean values ± s.e.m., n= independent clone). c Telomeric ChIP-dot-blot of SUZ12 in U2OS cells infected with scramble
or SUZ12 shRNA. IgG was used as a control. DNA input is also shown. (Graph) Quantiﬁcation of the signal from the immunoprecipitated telomeric repeats
normalized by the input (mean values ± s.e.m., n= technical triplicates). d Representative confocal STED super-resolution images showing the
colocalization between TRF2 (in green) and SUZ12 (in red) in U2OS cells. Zoom: a colocalization event. Scale bar 5 μm. e Telomeric ChIP-dot-blot for HP1
in WT and 20q-TERRA KO clones. IgG was used as a control. DNA input signal is also shown. (Left graph) Quantiﬁcation of the signal from the
immunoprecipitated telomeric repeats normalized by the input for each individual sample and (right graph) for all WT vs. 20q-TERRA KO clones (mean
values ± s.e.m., n= independent clone). Student’s t-test was used for statistical analysis (*p < 0.05 and **p < 0.01)
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previously described36, we observed that SUZ12 formed nuclear
foci (red dots in Fig. 4b). Interestingly, we found that
approximately 1.5 SUZ12 spots (in red) per nucleus colocalized
with TRF2 (in green; Fig. 4b), thus indicating the presence of the
SUZ12 PRC2 protein at telomeres. If we refer this quantiﬁcation
to the number of telomeres, 3.5% of the telomeres (as detected by
TRF2) colocalize with SUZ12. Importantly, SUZ12-TRF2 colo-
calization events were signiﬁcantly decreased by ~50% in 20q-
TERRA KO clones (#A7, #E1, #E6, and #C4) compared to the
WT clones (#1 and #2), demonstrating that the SUZ12 location to
telomeres was dependent on TERRAs (Fig. 4b). The speciﬁcity of
this reproducible, although low-in-number interaction, of SUZ12
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with the telomere was further conﬁrmed by immunoﬂuorescence
upon downregulation of PCR2 components with shRNAs or with
chemical inhibitors (see below). In addition, a SUZ12 ChIP
followed by telomeric dot-blot conﬁrmed this interaction of
SUZ12 with telomeric DNA, which was decreased upon down-
regulation of SUZ12 levels by shRNA (Fig. 4c). The deﬁnitive
proof of the interaction of SUZ12 with the telomere was achieved
by super-resolution microscopy (Fig. 4d). As seen in the confocal
super-resolution images, we found colocalization events between
SUZ12 and the telomeric-binding protein TRF2 (Fig. 4d).
Nevertheless, additional controls to prove this interaction were
performed by running three different types of randomization
approaches. First, we carried out a double immunoﬂuorescence of
SUZ12 and TRF2 run in parallel with one using an anti-
centromere antibody (ACA) and TRF2. As it can be seen in
Supplementary Fig. 1, the number of colocalizations between
SUZ12 and TRF2 was signiﬁcantly higher than the ones observed
by chance between TRF2 and the ACA antibody. Second, using
an interaction plugin on Fiji37, the interaction potential between
TRF2-SUZ12 was calculated. Interaction is deﬁned as the spatial
distribution of signal in one channel being not independent of the
signal distribution in the other channel. For that, objects were
identiﬁed and their NND (nearest neighbor distance) calculated,
and compared with one probability density function of the NND
if the signals were independent. For the Suz-TRF2 colocalizations
the strength of the interaction is superior to zero, indicating that
the spatial distribution of TRF2-SUZ12 is dependant (Supple-
mentary Fig. 2). When compared against 10,000 Monte Carlo
samples of NND distributions corresponding to the null
hypothesis of “no interaction”, the results are statistically
signiﬁcant (p < 0001). Third, we used the randomization tool of
the Deﬁniens Developer XD.2 software. In this way, TRF2 spots
were digitally found and a randomization of the TRF2 signal was
performed (16,000 randomized pictures; Supplementary Fig. 3A).
The number of TRF2 spots found in four original pictures and in
the ones randomized is shown in the Supplementary Fig. 3B
(please, note that each picture contains different number of
nuclei). Next, the colocalizations between TRF2 and SUZ12 were
identiﬁed both in the original and in the randomized pictures (see
Methods). Importantly, we found that the number of random
colocalizations was signiﬁcantly lower than in the original
pictures (Supplementary Fig. 3C). The percentage of randomized
pictures with ≥colocalizations is signiﬁcantly lower than in the
original pictures (Supplementary Fig. 3D). All together, these
ﬁndings demonstrate that SUZ12 interacts with the telomere and
that this interaction is TERRA-dependent.
TERRAs are necessary for HP1 recruitment to telomeres. We
previously showed that mammalian telomeres are enriched in
HP1, a mark of constitutive heterochromatin domains12. Here,
we set to study whether 20q-TERRA KO clones also showed
altered abundance of HP1 at telomeres. Interestingly, CHIP
analysis showed signiﬁcantly decreased HP1 abundance at the
telomeres of 20q-TERRA KO clones (#A7, #E1, #E6, and #C4)
compared to the WT clones (#1 and #2), demonstrating that
TERRAs are required for HP1 deposition at telomeres (Fig. 4e).
PRC2 complex is necessary for HP1 recruitment at telomeres.
Since we found that TERRAs are required for H3K9me3,
H3K27me3, PRC2, and HP1 recruitment at telomeres, we next set
up experiments to understand mechanistically the chain of events
for which TERRAs are responsible. PRC2 and H3K27me3 have
been previously to cooperate with H3K9me3 tri-methylation to
maintain HP1 at chromatin33. To assess whether this is also
happening at telomeres, we ﬁrst generated cells with decreased
EZH2 and SUZ12 levels by using two alternative methods. In
particular, we downregulated these PRC2 components using
shRNAs against EZH2 or SUZ12, as well as by using the speciﬁc
EZH2 chemical inhibitor EPZ-6438 (Fig. 5a,b). The down-
regulation obtained with the EZH2 shRNAs was ~70–90%. the
shRNA#2 being the most effective (Fig. 5a). The downregulation
obtained with the SUZ12 shRNA was 85% (Fig. 5a). In the case of
chemical inhibitors, we observed that the best EZH2 inhibition
was achieved at concentration of 1 µM of the inhibitor with a 90%
decrease in H3K27me3 global levels as determined by western
blot (Fig. 5b). Next, we studied the changes at telomeres as a
consequence of downregulating the PRC2 components. As
expected, we found a signiﬁcant decrease in global SUZ12 levels
as detected by immunoﬂuorescence in cells treated with either the
EZH2 or SUZ12 shRNAs or with the EZH2 inhibitor (Fig. 5c, left
bottom graphs). Consequently, the colocalization of SUZ12 with
the TRF2 telomeric protein decreased signiﬁcantly both with the
shRNAs or upon chemical inhibition (Fig. 5c, right bottom
graphs), conﬁrming the interaction of SUZ12 with the telomere.
Next, we evaluated the consequences of reduced PRC2 levels in
the deposition of heterochromatic marks by telomeric ChIP. As
expected because of the interaction of SUZ12 with the telomere,
telomeric H3K27me3 abundance decreased signiﬁcantly in cells
with reduced EZH2 or SUZ12 levels (Fig. 5d, left panel). More-
over, the levels of H3K9me3 and H4K20me3 also signiﬁcantly
dropped in these cells (Fig. 5d, middle and right panels), indi-
cating that PRC2 is not only important for the methylation of
H3K27 but also for the deposition of these other heterochromatic
marks. As a consequence of the drop in heterochromatic marks,
both global HP1 levels (Fig. 6a, left bottom graphs) and its
colocalization at telomeres (RAP1-HP1 colocalizations; Fig. 6a,
right bottom graphs) signiﬁcantly decreased both in cells treated
with either the PRC2 shRNAs or upon EZH2 inhibition as
observed by double immunoﬂuorescence of HP1 and the telo-
meric protein RAP1. Although the presence of HP1 is a well-
established mark at the telomere12,38, we performed an additional
control to prove the speciﬁcity of the HP1 antibody and of this
interaction consisting of a double immunoﬂuorescence of HP1
and the telomere-binding protein RAP1 run in parallel with one
Fig. 5 The PRC2 complex is critical for the deposition of heterochromatic histone marks and HP1 at telomeres. a Upon infection of U2OS cells with shRNAs
against EZH2 and SUZ12, total protein was obtained and used for western blot detection of EZH2 and SUZ12. Actin was used as loading control. b U2OS
were treated with increasing concentrations of the EZH2 inhibitor EPZ-6438 for 4 days. Nuclear protein extracts were used for western blot detection of
H3K27me3. Actin was used as loading control. (Graph) Quantiﬁcation is shown. c Representative images of the average number of colocalizations for TRF2
(green) and SUZ12 (red) in U2OS cells infected with a scramble or with EZH2 or SUZ12 shRNAs (left panel) or treated with vehicle or EZH2 inhibitor.
Arrowheads indicate colocalization events. Scale bar, 10 μm. Below the images is shown the quantiﬁcation of (left graphs) the total nuclear SUZ12 upon
shRNAs or EZH2 inhibitor and (right graphs) the colocalization between TRF2 and SUZ12 (mean values ± s.e.m., n= number of cells). d Telomeric ChIP-
dot-blot of the H3K27m3, H3K9m3, and H4K20m3 for U2OS cells infected with scramble, EZH2, or SUZ12 shRNAs. IgG was used as a control. IgG ChIP-
dot-blot shared by different antibodies shows different exposure times according to the best exposure time required for each antibody. DNA input signal is
also shown. Quantiﬁcation of the immunoprecipitated telomeric repeat signal normalized by the input for each individual sample is shown below (mean
values ± s.e.m., n= technical replicates). Student’s t-test was used for the statistical analysis (*p < 0.05, **p < 0.01, and ***p < 0.001)
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using ACA (antibody that recognizes the centromere) and RAP1.
As can be seen in Supplementary Fig. 4, the number of coloca-
lizations between HP1 and RAP1 was signiﬁcantly higher than
the ones observed by chance between RAP1 and the ACA signal.
Similar to SUZ12 interaction with the telomere (see above), we
performed two additional randomization approaches to prove the
HP1–RAP1 interaction. First, using an interaction plugin on
Fiji37 we found that the strength of the interaction HP1–RAP1 is
superior to zero, indicating that the spatial distribution of RAP1-
HP1 is dependent (Supplementary Fig. 5). When compared
against 10,000 Monte Carlo samples of NND distributions cor-
responding to the null hypothesis of “no interaction”, the results
are statistically signiﬁcant (p < 0.0001). Second, using the rando-
mization tool of the Deﬁniens Developer XD.2 software, we ﬁrst
detected digitally RAP1 spots in the original and in 4.800
randomized pictures. (Supplementary Fig. 6A). The number of
RAP1 spots found in four original pictures and in the ones
randomized is shown in the Supplementary Fig. 6B (please, note
that each picture contains different number of nuclei). Next, the
colocalizations between RAP1 and HP1 were identiﬁed both in
the original and in the randomized pictures (see Methods).
Importantly, we found that the number of random colocalizations
was signiﬁcantly lower than in the original pictures (Supple-
mentary Fig. 6C). The percentage of randomized pictures with
≥colocalizations is signiﬁcantly lower than in the original pictures
(p > 0.01; Supplementary Fig. 6D). Moreover, we conﬁrmed the
signiﬁcant decrease in HP1 abundance at telomeres by telomeric
ChIP in cells with reduced EZH2 or SUZ12 levels (Fig. 6b). Note
that HP1 levels do not change upon downregulation of either
EZH2 or SUZ12 (Supplementary Fig. 7)
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Fig. 6 Global HP1 and its localization at telomeres depend on PRC2 levels. a Representative images of the average number of colocalizations of RAP1
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Arrowheads indicate colocalization events. Scale bar, 10 μm. Quantiﬁcation of (left graphs) total HP1 and (right graphs) the colocalization between RAP1
and HP1 (mean values ± s.e.m., n= number of cells). b Telomeric ChIP-dot-blot of the HP1 protein for the U2OS cells infected with scramble, EZH2, or
SUZ12 shRNA. IgG was used as a control. DNA input signal is also shown. Quantiﬁcation of the immunoprecipitated telomeric repeats normalized by the
input is shown below (mean values ± s.e.m., n= technical replicates). Student’s t-test was used for the statistical analysis (*p < 0.05, **p < 0.01, and ***p <
0.001)
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Together, these results are in agreement with a model in which
TERRAs interact with the PRC2 complex, and this interaction is
important for PRC2 deposition to telomeres. In turn, this
deposition is critical for the establishment of the H3K27me3
histone mark at telomeres, as well as for the subsequent assembly
of H3K9me3 and H4K20m34 heterochromatin marks. Upon the
establishment of these marks, HP1 is recruited to telomeres
(Fig. 7).
TERRAs do not affect subtelomeric and total DNA methyla-
tion. Given the role of TERRAs in heterochromatin assembly at
telomeric chromatin, we next studied whether TERRAs can also
inﬂuence subtelomeric DNA methylation as well as global DNA
methylation. Subtelomeric DNA is highly methylated at CpG-rich
regions10,11, being the methylation of the D4Z4 repeat repre-
sentative of the methylation state of the subtelomere. For this
reason, we performed bisulﬁte pyrosequencing to evaluate the
DNA methylation levels at the D4Z4 repeats in our panel of cells
WT and 20q-TERRA KO. We did not observe differences in the
different CpG analyzed (cytosines C1, 2, and 3) between the 20q-
TERRA KO clones and the WT clones (Supplementary Fig. 8).
The slight differences found between clones of the same genotype
might be related to inner differences between the clones (Sup-
plementary Fig. 8A). When we calculated the percentage of
changes in methylated CpG of the 20q-TERRA KO clones with
respect to the control, we did not ﬁnd any statistical differences
between the WT clones and the 20q-TERRA KO clones, in any of
the cytosine evaluated (Supplementary Fig. 8B).
To assess the role of TERRAs in total DNA methylation, we
performed bisulﬁte pyrosequencing on LINE1 repeats, which are
representative of the global DNA methylation state. As with the
subtelomeric DNA methylation, we did not ﬁnd differences
between the WT and the 20q-TERRA KO clones (Supplementary
Fig. 8C). When we calculated the percent increase of methylated
CpG of the 20q-TERRA KO clones with respect to the WT pool,
we did not ﬁnd signiﬁcant differences either (Supplementary
Fig. 8D). CpG methylation at Alu repeats was used as control
(Supplementary Fig. 8E).
The above data indicate that TERRAs do not have a clear role
on subtelomeric and total DNA methylation.
Discussion
Telomeres are known to be enriched in heterochromatin histone
tri-methylation marks, namely H3K9me3 and H4K20me3, as well
as HP1 binding12,39,40, thus being part of the so-called con-
stitutive heterochromatin. In addition, subtelomeric DNA is
hypermethylated7,11,13. Both histone and DNA hypermethylation
marks contribute to the repressive environment at telomeres,
acting as negative regulators of telomere length and telomere
recombination8–13. Interestingly, TERRAs are known to bind
both in cis and in trans to telomeric chromatin15,16,18; however,
the roles of TERRAs at the assembly of telomeric chromatin are
still vaguely deﬁned owing to lack of TERRA knockout models,
although an interaction between TERRAs and H3K9me3 and
HP1 has been described before21.
We recently showed that the majority of TERRAs in human
U2OS ALT cells arise from the 20q-TERRA locus20. We have also
generated human U2OS cells knockout for this 20q-TERRA
locus, and showed that this resulted in markedly decreased global
TERRA levels, as well as loss of telomere protection and telomere
shortening20. Here, we used this TERRA knockout cellular model
to address the role of TERRAs in the establishment of telomeric
chromatin. We found that human U2OS cells KO for 20q-
TERRA show decreased abundance of the heterochromatin
H3K9me3 and H4K20m3 histone tri-methylation marks at telo-
meres, previously shown by us to be important for the repressive
environment of telomeres12,39,40. In addition, we found that DNA
hypermethylation of subtelomeric sequences, which is another
feature of telomeric chromatin11, was not affected by TERRA
depletion, indicating that this mark is independent of TERRA
levels. Therefore, our results demonstrate that TERRAs are
necessary for the establishment of the bona ﬁde H3K9me3 and
H4K20m3 heterochromatic histone marks at telomeres but not
for subtelomeric DNA hypermethylation.
Interestingly, we found that 20q-TERRA KO cells also showed
a decreased abundance of the facultative heterochromatin mark
Subtelomere Telomere
Subtelomere Telomere
EED
EZH2
Suz12
HP1
H3
H4
K27me3
K9me3
K20me3
TERRA
20q-TERRA KO cellsWT cells
Fig. 7 Model of TERRAs as a master regulator of the heterochromatic status of the telomere. Diagram showing how TERRA recruits the PRC2 complex
(EED, EZH2, SUZ12) and directs it to the telomere. Upon binding of PRC2 to the telomere, PRC2 catalyzes H3K27 methylation. This mark facilitates then
the deposition of H3K9m3 and H4K20m3 and the recruitment and stabilization of HP1 protein at the telomere, important to maintain the heterochromatic
status of the telomere. In the 20q-TERRA KO cells PRC2 is not recruited to the telomere, and the heterochomatic marks and HP1 protein are not taking
place
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H3K27me3 at telomeres, which has only been described in lower
eukaryotes such as unicellular algae41. In the ﬁlamentous fungus
Neurospora crassa the H3K27me2/3 mark is principally sub-
telomeric covering ≈7% of the genome, and its loss results in
telomere mislocalization and alterations in normal chromosome
conformation42. As this mark is established by the Polycomb
Repressive Complex 2 (PRC2) we next seek whether there was a
direct interaction between TERRAs and the PRC2 complex. We
found that TERRAs directly bound to the PRC2 components
EZH2 and SUZ12. Furthermore, we saw that SUZ12 speciﬁcally
colocalized with telomeric chromatin by different techniques,
including immunoprecipitation of SUZ12 followed by telomeric
dot-blot and, more importantly, by colocalization of SUZ12 with
the telomeric binding protein TRF2, using super-resolution
confocal microscopy. Interestingly, this interaction was
decreased in the absence of TERRAs. These ﬁndings are in
agreement with a recent report indicating that TERRA location to
extratelomeric sites inﬂuences H3K27 deposition at these sites
through interaction with the PRC217.
Our data support a role of TERRAs as key factors in the
deposition of heterochromatic marks at telomeres in ALT human
cells. It was shown before that TERRA binds H3K9me3 and HP1
(ref. 21) but here we have completed the picture with the ﬁnding
of PRC2 being the TERRA mediator for the heterochromatization
of human telomeres. Thus, we found that TERRAs interact with
PRC2 and that PRC2 depletion leads to loss of heterochromatic
marks at telomeres. Interestingly, genome-wide targeting of PRC2
depends on ATRX43. However, U2OS cells lack ATRX and,
therefore, it is quite possible that both PRC2 localization to tel-
omeres and the interplay between facultative and heterochro-
matic marks at telomeres in U2OS cells is very different from
those in telomerase-positive cells. Moreover, ALT cells are
defective in the cell cycle regulation of TERRA and neither the
levels of TERRA nor the colocalization of TERRA at telomeres
declined from S to G2 as it occurs in telomerase-positive cells22.
This persistent TERRA presence at telomeres might be important
for PRC2 recruitment in the absence of ATRX. On the other
hand, the binding of TERRAs to PRC2 is conserved in mammals
as it was also identiﬁed to occur in mouse embryonic stem cells17.
In this murine cells, TERRA binding was strongly correlated with
H3K27me3 genome wide17, supporting our ﬁnding of TERRA
regulating H3K27me3 levels in human telomeres. We went one
step further and found that TERRAs do not only regulate
H3K27me3 deposition but also H3K9me3, H4K20me3 and HP1
and that this is mediated by PRC2. According to the role
described for PRC2 and H3K27me3 cooperating with H3K9
methylation to maintain HP1 at chromatin33, our ﬁndings at
telomeres are also in agreement with this heterochromatization
process. Moreover, our data indicate that TERRAs would be the
key molecule to lead this process. Whether this important role
could be extensive to telomerase-positive cells awaits to be tested.
In summary, we describe for the ﬁrst time a role for PRC2 in the
establishment of telomeric chromatin, which is regulated by
TERRAs. In addition, we demonstrate an important role for
TERRAs in telomeric heterochromatin assembly.
Methods
Cells, transfection, infection and treatments. Human U2OS (ATCC) were
cultured according to the ATCC’s recommendations. Plasmids were electroporated
using the Neon Transfection System (Invitrogen) following the manufacturers’
protocol. U2OS cells were infected with an shRNA against the PRC2 complex
subunits, which were cloned into Plko.1-Puro vector (shRNA sequence available in
Supplementary Table 1). Lentiviruses were packaged in 293T cells (ATCC-CRL-
3216) using the third-generation packaging system vectors, pMDLg/pRRE, pRSV.
Rev, pMDG VSVG. Cells were seeded at a 50% of conﬂuency 24 h before infection.
Two infections were performed every 24 h by adding 3 ml of viral supernatant.
Then, cells were allowed to recover for 24 h in growth medium before undergoing
selection with puromycin for 2 days. For EZH2 inhibition U2OS cells were cultured
with DMEM that contained different concentrations of the EZH2 inhibitor EPZ-
6438 (SELLECKCHEM) for 4 days.
Generation of TERRA KO clones using the CRISPR-Cas9 system. The 20q-
TERRA KO clones were generated using an all-in-one plasmid that contains the
two gRNAs (S2 and E1) needed for the deletion of the 20q-TERRA locus. The
backbone of the all-in-one plasmid was the pSpCas9(BB)-2A-GFP that already
contains the S2 gRNA20. The gRNA End1 (E1) with the U6 promoter was
ampliﬁed by PCR adding Not1 restriction sequence (primers available in Supple-
mentary Table 1) with the GoTaq polymerase (Promega) using as template the
pSpCas9(BB)-2A-GFP that already contains the E1 gRNA20. The PCR product and
the pSpCas9(BB)-2A-GFP containing the Start 2 (S2) gRNA20 were digested with
the Not1 enzyme (New England Biolabs) during 4 h at 37 °C, and after ligation was
performed at 16 °C overnight with the T4 DNA ligase enzyme (New England
Biolabs). The plasmid with the new insert was transformed in One Shot TOP10
Chemically Competent E. coli DH5α (Invitrogen) and plated on LB agar plates
with penicillin. The plasmid was puriﬁed with Plasmid Miniprep Kit (QIAGEN)
and the presence of the insert conﬁrmed with Sanger-style BigDye terminator
chemistry on an ABI 3730 × l sequencer (Applied Biosystems). Then, the all-in-one
plasmid containing the Cas9, both gRNA (S2 and E1), and a GFP cassette was
transiently electroporated into the cells using the Neon system. Two days after
transfection cells were trypsinized, washed with dPBS, and three or ﬁve cells of the
10% GFP brightest ones were sorted using the FACS ARIA IIU (Becton Dickinson)
and plated into 96-well plates. Two weeks later, wells were checked for monoclonal
cell expansion and those clones were selected for genotyping by PCR. Homozygous
monoclonal cell lines were expanded. PCR primers used for genotyping can be
found in Supplementary Table 1.
RNA dot-blot. RNA dot-blot analyses were performed using standard protocols.
TERRA probe was obtained from a 1.6-kb (TTAGGG)n cDNA insert excised from
pNYH3 (kind gift from T. de Lange, Rockefeller University, NY, USA). Dot-blot
was normalized using 18S probes and quantiﬁed using ImageJ. The probes were
labeled using the commercial Prime-It II Random Primer Labeling Kit (Agilent
Genomics).
RNA-FISH. Cells grown on poly-L-lysine-coated coverslips (Becton Dickinson)
were placed in cytobuffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM
pipes pH 6.8) for 30 s, washed in cytobuffer with 0.5% Triton X-100 for 30 s,
washed in cytobuffer for 30 s, and then ﬁxed for 10 min in 4% paraformaldehyde in
phosphate-buffered saline (PBS). The cells were dehydrated in 70, 80, 95, and 100%
ethanol, air-dried, and hybridized overnight at 37 °C with a telomere-speciﬁc PNA-
FITC probe (Panagene) in hybridization buffer (2 × sodium saline citrate (SSC)/
50% formamide). Coverslips were washed two times for 15 min in hybridization
buffer at 40 °C, two times for 10 min in 2 × SSC at 40 °C, 10 min in 1 × SSC at 40 °
C, 5 min in 4 × SSC at room temperature, 5 min in 4 × SSC containing 0.1% Tween-
20 and DAPI (Molecular Probes) at room temperature, and 5 min in 4 × SSC at
room temperature. Signals were visualized in a confocal ultraspectral microscope
SP5-WLL (Leica). TERRA signal was quantiﬁed using the Deﬁniens Developer
XD.2 software.
High-throughput telomere length quantiﬁcation by FISH. HT-q-FISH was done
according to ref. 44. Cells were plated into clear-bottom black-walled 96-well plates
pre-coated for 30 min with 0.1% porcine gelatin. Then, cells were grown in DMEM
at 37 °C overnight, ﬁxed in methanol/acetic acid (3:1, v/v) two times for 10 min,
and were left in the ﬁxative overnight at −20 °C. Fixative was removed, plates dried
for at least 1 h at 37 °C, and samples were rehydrated in PBS. Plates were then
subjected to a standard Q-FISH protocol using a telomere-speciﬁc PNA-CY3
probe; DAPI was used to stain nuclei. Images were captured using the OPERA
(Perkin Elmer) High-Content Screening system. TL values were analyzed using
individual telomere spots. Samples were analyzed in triplicate.
Biotin pull-down analysis. Biotin pull-down assays were carried out as described
in ref. 45 except for that 150 μg of nuclear lysate were incubated with 0.9 ng of
biotinylated transcripts (Invitrogen) for 1 h at room temperature. An amount of
0.9 ng of total RNA was added as competitor. Complexes were isolated using
streptavidin-conjugated Dynabeads (Dynal), and bound proteins in the pull-down
material were analyzed by western blotting. The biotinylated TERRA sense tran-
script consists of 8 × UUAGGG; the control biotinylated transcripts consist of the
TERRA antisense sequence 8 × CCCUAAA. See antibodies in the western blot
section. Full gels can be found in Supplementary Fig. 9.
Western blot analysis. Whole-cell lysates and nuclear lysates were prepared using
RIPA buffer and RSB buffer (10 mM Tris-HCl (pH 7.5), 10 mM NaCl, 3 mM
MgCl2, and inhibitors), respectively, as previously described19. Protein lysates were
resolved by SDS–PAGE and transferred onto nitrocellulose membranes. Antibodies
used were the following: EZH2 (D2C9; Cell signaling), SUZ12 (ab12073; Abcam),
H3K27m3 (07–449; Millipore), HP1γ (clone 42S2; Millipore), and ACTIN (A5441;
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Sigma-Aldrich). Following secondary antibody incubations, signals were visualized
by enhanced chemiluminescence. Full gels can be found in Supplementary Fig. 9.
Immunoﬂuorescence and super-resolution microscopy. Cells grown on poly-L-
lysine-coated coverslips (Becton Dickinson) were placed in cytobuffer (100 mM
NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM pipes pH 6.8) with 0.5% Triton X-
100 for 6 min and then ﬁxed for 10 min in 4% paraformaldehyde in PBS. Cells were
blocked with 10% BSA in PBS for 1 h at room temperature. Cells were incubated
with primary antibody dissolved in Dako antibody Diluent (Dako) for 1 h in a
humid chamber at room temperature. Coverslips were washed three times for 30
min in PBS containing 0.1% Tween-20. Cells were incubated with Alexa secondary
antibody (Life Technologies, A11017) dissolved in Dako antibody Diluent (Dako)
for 1 h in a humid chamber at room temperature. Cells were washed three times for
30 min in PBS containing 0.1% Tween-20. Samples were mounted in Prolong with
DAPI (Invitrogen). Signals were visualized in a confocal ultraspectral microscope
SP5-WLL (Leica). The following antibodies were used: TRF2 (clone 4A794; Mil-
lipore) diluted 1/250, SUZ12 (ab12073; Abcam) diluted 1/500, RAP1 (A300–306A;
Bethy) diluted 1/250, HP1γ (clone 42S2; Millipore) diluted 1/200, and Anti Cen-
tromere Antibody (ACA; 15–235; Antibodies Incorporated) diluted 1/100. For
Super-resolution microscopy acquisition, we use a confocal multispectral Leica
TCS SP8 system with a 3 × STED module for super-resolution. Laser lines: 405 nm
and WLL2 (white laser for 470–670 nm excitation). Depletion lines: 592 and 660
nm.
Randomization analysis. Two different randomization analyses were performed.
First, the MosacIA Fiji plugin (https://imagej.net/Interaction_Analysis)37,46 was
used to calculate the interaction potentials. Potential used was Plummer (100
iterations). Grid spacing was 0.5 pixels. Kernel wt(q) was 0.001. Kernel wt(p) was
provided by the plugin using Silverman’s rule. The results were tested for sig-
niﬁcance against 10,000 Monte Carlo samples of point distributions corresponding
to the null hypothesis of “no interaction”47. Second, the randomization tool of the
Deﬁniens Developer XD.2 software was used. TRF2 spots were found in DNA-
positive nuclear areas. Those regions without DNA signal, where TRF2 is not found
but SUZ12 is detected (as in the nucleoli), were eliminated from the analysis.
Colocalizations between TRF2 and SUZ12 were identiﬁed according to
SUZ12 signal intensity and a colocalization of TRF2 signal on SUZ12 of more than
60%. The number of colocalizations between SUZ12 and the virtual TRF2 spots
were calculated using the same criteria for the original and randomized images. In
all, 16,000 randomized pictures were generated. In a similar manner, the coloca-
lizations of RAP1-HP1 were calculated in the original pictures and in 4.800 ran-
domized pictures. The RAP1 spots were detected in the entire nucleus.
ChIP assay and telomere dot-blots. For ChIP analysis, we used 4 × 106 cells per
condition. Formaldehyde was added directly to tissue culture medium to a ﬁnal
concentration of 1% and left for 10 min at room temperature on a shaking plat-
form. The crosslinking was stopped by adding glycine to a ﬁnal concentration of
0.125 M. Crosslinked cells were washed twice with cold PBS, scraped and lysed at a
density of 5 × 106 cells ml−1 for 10 min at 4°C in 1% SDS, 50 mM Tris-HCl (pH
8.0) and 10 mM EDTA containing protease inhibitors. Lysates were sonicated to
obtain chromatin fragments <1 kb and centrifuged for 15 min in a microfuge at
room temperature. An aliquot of 200 µl of lysate was diluted 1:10 with 1.1% Triton
X-100, 2 mM EDTA, 150 mM NaCl, and 20 mM Tris-HCl (pH 8.0) containing
protease inhibitors, and precleared with 50 µl of Protein A/G Plus-Agarose sc-2003
beads (Santa Cruz Biotechnology). After centrifugation, the fragments were incu-
bated with 4 µg of the following antibodies: H3K27m3 (07–449, Millipore),
H3K9m3 (07–442, Upstate), H4K20m3 (07–749, Upstate), H3K4m3 (CS200580,
Millipore), H3K9ac (072K4824, Sigma-Aldrich), H4K16ac (cat39167, Active
Motif), or normal rabbit IgG (Santa Cruz Biotechnology) and 10 µg of: HP1γ
(clone 42S2; Millipore) and SUZ12 (ab12073; Abcam) diluted at 4 °C overnight on
a rotating platform. Next day, 50 µl of Protein A/G Plus-Agarose (sc-2003) beads
were added and incubated for 1 h. The immunoprecipitated pellets were washed
once with 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.0),
and 150 mM NaCl, and then with 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20
mM Tris-HCl (pH 8.0), and 500 mM NaCl, and next with 0.25M LiCl, 1% Nonidet
P-40, 1% sodium deoxycholate, 1 mM EDTA, and 10 mM Tris-HCl, pH 8.0 and
ﬁnally with 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA two times. The chromatin
was eluted from the beads twice by incubation with 250 µl 1% SDS and 0.1 M
NaHCO3 during 15 min at room temperature with rotation. After adding 20 µl of 5
M NaCl, the crosslink was reversed overnight at 65 °C. Samples were supplemented
with 20 µl of 1 M Tris-HCl (pH 6.5), 10 µl of 0.5 M EDTA, 20 µg of RNase A, and
40 µg of proteinase K, and were incubated for 1 h at 45 °C. DNA was recovered by
phenol–chloroform extraction and ethanol precipitation, slot-blotted it onto a
Hybond N+membrane, and hybridized it with a plasmid containing 1.6 Kb of
TTAGGG repeats (gift from T. de Lange, Rockefeller University, USA). The signal
was quantiﬁed with the ImageJ software. For total telomeric DNA samples, 500 µl
of lysate was processed with the rest of the samples at the step of reversing the
crosslinks. The amount of telomeric DNA immunoprecipitated was calculated in
each ChIP based on the signal relative to the corresponding total telomeric DNA
signal. Full blots can be found in Supplementary Fig. 9.
Data availability. All relevant data are available from the authors.
Received: 12 October 2017 Accepted: 20 March 2018
References
1. Chan, S. W. & Blackburn, E. H. New ways not to make ends meet: telomerase,
DNA damage proteins and heterochromatin. Oncogene 21, 553–563 (2002).
2. de Lange, T. Shelterin: the protein complex that shapes and safeguards human
telomeres. Genes Dev. 19, 2100–2110 (2005).
3. Funk, W. D. et al. Telomerase expression restores dermal integrity to in vitro-
aged ﬁbroblasts in a reconstituted skin model. Exp. Cell Res. 258, 270–278
(2000).
4. Blasco, M. A., Funk, W., Villeponteau, B. & Greider, C. W. Functional
characterization and developmental regulation of mouse telomerase RNA.
Science 269, 1267–1270 (1995).
5. Shay, J. W. & Wright, W. E. Role of telomeres and telomerase in cancer.
Semin. Cancer Biol. 21, 349–353 (2011).
6. Dunham, M. A., Neumann, A. A., Fasching, C. L. & Reddel, R. R. Telomere
maintenance by recombination in human cells. Nat. Genet. 26, 447–450
(2000).
7. Blasco, M. A. The epigenetic regulation of mammalian telomeres. Nat. Rev.
Genet. 8, 299–309 (2007).
8. Benetti, R., Garcia-Cao, M. & Blasco, M. A. Telomere length regulates the
epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 39,
243–250 (2007).
9. Benetti, R. et al. Suv4-20h deﬁciency results in telomere elongation and
derepression of telomere recombination. J. Cell Biol. 178, 925–936 (2007).
10. Brock, G. J., Charlton, J. & Bird, A. Densely methylated sequences that are
preferentially localized at telomere-proximal regions of human chromosomes.
Gene 240, 269–277 (1999).
11. Gonzalo, S. et al. DNA methyltransferases control telomere length and
telomere recombination in mammalian cells. Nat. Cell Biol. 8, 416–424 (2006).
12. Garcia-Cao, M., O’Sullivan, R., Peters, A. H., Jenuwein, T. & Blasco, M. A.
Epigenetic regulation of telomere length in mammalian cells by the Suv39h1
and Suv39h2 histone methyltransferases. Nat. Genet. 36, 94–99 (2004).
13. Schoeftner, S. & Blasco, M. A. A ‘higher order’ of telomere regulation:
telomere heterochromatin and telomeric RNAs. EMBO J. 28, 2323–2336
(2009).
14. Marion, R. M. et al. Telomeres acquire embryonic stem cell characteristics in
induced pluripotent stem cells. Cell Stem. Cell. 4, 141–154 (2009).
15. Azzalin, C. M., Reichenbach, P., Khoriauli, L., Giulotto, E. & Lingner, J.
Telomeric repeat containing RNA and RNA surveillance factors at
mammalian chromosome ends. Science 318, 798–801 (2007).
16. Schoeftner, S. & Blasco, M. A. Developmentally regulated transcription of
mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol.
10, 228–236 (2008).
17. Chu, H. P. et al. TERRA RNA antagonizes ATRX and protects telomeres. Cell
170, 86–101 e116 (2017).
18. Lopez de Silanes, I. et al. Identiﬁcation of TERRA locus unveils a telomere
protection role through association to nearly all chromosomes. Nat. Commun.
5, 4723 (2014).
19. Lopez de Silanes, I., Stagno d’Alcontres, M. & Blasco, M. A. TERRA
transcripts are bound by a complex array of RNA-binding proteins. Nat.
Commun. 1, 33 (2010).
20. Montero, J. J., Lopez de Silanes, I., Grana, O. & Blasco, M. A. Telomeric RNAs
are essential to maintain telomeres. Nat. Commun. 7, 12534 (2016).
21. Deng, Z., Norseen, J., Wiedmer, A., Riethman, H. & Lieberman, P. M. TERRA
RNA binding to TRF2 facilitates heterochromatin formation and ORC
recruitment at telomeres. Mol. Cell 35, 403–413 (2009).
22. Flynn, R. L. et al. Alternative lengthening of telomeres renders cancer cells
hypersensitive to ATR inhibitors. Science 347, 273–277 (2015).
23. Flynn, R. L. et al. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch
on telomeric single-stranded DNA. Nature 471, 532–536 (2011).
24. Graf, M. et al. Telomere length determines TERRA and R-loop regulation
through the cell cycle. Cell 170, 72–85 e14 (2017).
25. Balk, B. et al. Telomeric RNA-DNA hybrids affect telomere-length dynamics
and senescence. Nat. Struct. Mol. Biol. 20, 1199–1205 (2013).
26. Arora, R. et al. RNaseH1 regulates TERRA-telomeric DNA hybrids and
telomere maintenance in ALT tumour cells. Nat. Commun. 5, 5220 (2014).
27. Rinn, J. L. et al. Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell 129, 1311–1323
(2007).
28. Bernstein, E. & Allis, C. D. RNA meets chromatin. Genes Dev. 19, 1635–1655
(2005).
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03916-3 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:1548 | DOI: 10.1038/s41467-018-03916-3 | www.nature.com/naturecommunications 13
29. Muller, S. & Almouzni, G. Chromatin dynamics during the cell cycle at
centromeres. Nat. Rev. Genet. 18, 192–208 (2017).
30. Castellano-Pozo, M. et al. R loops are linked to histone H3 S10
phosphorylation and chromatin condensation. Mol. Cell 52, 583–590 (2013).
31. Skourti-Stathaki, K., Kamieniarz-Gdula, K. & Proudfoot, N. J. R-loops induce
repressive chromatin marks over mammalian gene terminators. Nature 516,
436–439 (2014).
32. Torres-Ruiz, R. et al. Efﬁcient recreation of t(11;22) EWSR1-FLI1+ in human
stem cells using CRISPR/Cas9. Stem Cell Rep. 8, 1408–1420 (2017).
33. Boros, J., Arnoult, N., Stroobant, V., Collet, J. F. & Decottignies, A. Polycomb
repressive complex 2 and H3K27me3 cooperate with H3K9 methylation to
maintain heterochromatin protein 1alpha at chromatin. Mol. Cell Biol. 34,
3662–3674 (2014).
34. Muller, J. et al. Histone methyltransferase activity of a Drosophila Polycomb
group repressor complex. Cell 111, 197–208 (2002).
35. Wang, X. et al. Targeting of polycomb repressive complex 2 to RNA by short
repeats of consecutive guanines. Mol. Cell 65, 1056–1067 e1055 (2017).
36. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J. & Lee, J. T. Polycomb proteins
targeted by a short repeat RNA to the mouse X chromosome. Science 322,
750–756 (2008).
37. Shivanandan, A., Radenovic, A. & Sbalzarini, I. F. MosaicIA: an ImageJ/Fiji
plugin for spatial pattern and interaction analysis. BMC Bioinformatics 14, 349
(2013).
38. Canudas, S. et al. A role for heterochromatin protein 1gamma at human
telomeres. Genes Dev. 25, 1807–1819 (2011).
39. Garcia-Cao, M., Gonzalo, S., Dean, D. & Blasco, M. A. A role for the Rb family
of proteins in controlling telomere length. Nat. Genet. 32, 415–419 (2002).
40. Gonzalo, S. et al. Role of the RB1 family in stabilizing histone methylation at
constitutive heterochromatin. Nat. Cell Biol. 7, 420–428 (2005).
41. Mikulski, P., Komarynets, O., Fachinelli, F., Weber, A. P. M. & Schubert, D.
Characterization of the polycomb-group mark H3K27me3 in unicellular algae.
Front. Plant Sci. 8, 607 (2017).
42. Klocko, A. D. et al. Normal chromosome conformation depends on
subtelomeric facultative heterochromatin in Neurospora crassa. Proc. Natl
Acad. Sci. USA 113, 15048–15053 (2016).
43. Sarma, K. et al. ATRX directs binding of PRC2 to Xist RNA and Polycomb
targets. Cell 159, 869–883 (2014).
44. Canela, A., Klatt, P. & Blasco, M. A. Telomere length analysis. Methods Mol.
Biol. 371, 45–72 (2007).
45. Wang, W. et al. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell
Biol. 20, 760–769 (2000).
46. Helmuth, J. A., Paul, G. & Sbalzarini, I. F. Beyond colocalization: inferring
spatial interactions between sub-cellular structures from microscopy images.
BMC Bioinformatics 11, 372 (2010).
47. Silverman, B. W. Density Estimation for Statistics and Data Analysis.
Monographs on Statistics and Applied Probability book series (Chapman and
Hall, London, 1986).
Acknowledgements
We thank to R. Torres and S. Rodriguez for advice in the CRISPR-Cas9 technology and
helpful discussions. We are indebted to Sylvia Gutiérrez Erlandsson, principal investi-
gator of the confocal microscopy Group at the National Centre of Biotechnology, Madrid
(Spain), because, without her generous help, we could not have performed the super-
resolution microscopy. Research in the Blasco lab is funded by the Spanish Ministry of
Economy and Competitiveness Projects (SAF2013-45111-R and SAF2015-72455-EXP),
the World Cancer Research (WCR) Project (16-1177), and the Fundación Botín (Spain).
Author contribution
M.A.B. conceived the original idea. J.J.M. conducted and analyzed the experiments. J.J.
M., I.L.S., and M.A.B. designed the experiments, D.M. did the super-resolution micro-
scopy acquisition and performed the immunoﬂuorescence image quantiﬁcation and the
Deﬁniens randomization. A.C.G. did the MosaicIA randomization analysis. M.F.F.
performed the DNA methylation analysis; J.J.M., I.L.S., and M.A.B. wrote the
manuscript.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
018-03916-3.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2018
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03916-3
14 NATURE COMMUNICATIONS |  (2018) 9:1548 | DOI: 10.1038/s41467-018-03916-3 | www.nature.com/naturecommunications
